Being tested
Corticosteroids (relapse treatment): reduce relapses and new lesions in optic neuritis
optic neuritis · Corticosteroids (relapse treatment)
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 6
- Running now
- 2
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 210
No controlled trial has reported a result yet.
Other linked trials: 6
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Other linked trials: 6
These linked trials do not set the status.
Phase 4 · 2012 · Not randomised
- PIONEER-1Ongoing
Phase 3 · 2026 · Placebo-controlled
- TIMELY-PLEXOngoing
Phase 3 · 2025 · Not randomised
Phase 2/3 · 2021 · Placebo-controlled
- Optic Neuritis Recovery After Oral or IV CorticosteroidsResult in a paper, not read yet
Phase 2/3 · 2012 · Not randomised
- ACHTARResult in a paper, not read yet
Phase early 1 · 2013 · Not randomised
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-27First listed as Being tested
Related hypotheses
- Corticosteroids (relapse treatment): prevent attacks in NMOSD
- Corticosteroids (relapse treatment): reduce relapses and new lesions in primary progressive MS
- Corticosteroids (relapse treatment): reduce relapses and new lesions in relapsing MS
- Corticosteroids (relapse treatment): reduce relapses and new lesions in relapsing and progressive MS
- Corticosteroids (relapse treatment): reduce relapses and new lesions in secondary progressive MS
- Corticosteroids (relapse treatment): reduce relapses and new lesions in MS (type not specified)
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error